TSPO and glioblastoma: One pilot study evaluating the TSPO PET tracer 11C-PBR28 in patients with primary glioblastoma multiforme or melanoma brain metastasis, treated with chemoradiation or immunotherapy, was completed recently; the results are to be determined (NCT02431572) (29).